These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21504375)

  • 1. Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods.
    Viette V; Fathi M; Rudaz S; Hochstrasser D; Veuthey JL
    Clin Chem Lab Med; 2011 Jul; 49(7):1091-103. PubMed ID: 21504375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS (/MS) in clinical toxicology screening methods.
    Viette V; Hochstrasser D; Fathi M
    Chimia (Aarau); 2012; 66(5):339-42. PubMed ID: 22867548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review.
    Peters FT; Remane D
    Anal Bioanal Chem; 2012 Jun; 403(8):2155-72. PubMed ID: 22549818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-analyte procedures for screening for and quantification of drugs in blood, plasma, or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology.
    Maurer HH
    Clin Biochem; 2005 Apr; 38(4):310-8. PubMed ID: 15766732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
    Garg U; Zhang YV
    Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
    Roux A; Lison D; Junot C; Heilier JF
    Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of liquid chromatography--mass spectrometry in analytical toxicology: a review.
    Hoja H; Marquet P; Verneuil B; Lotfi H; Pénicaut B; Lachâtre G
    J Anal Toxicol; 1997; 21(2):116-26. PubMed ID: 9083829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the future of (ultra) high performance liquid chromatography coupled to low and high resolution mass spectrometry for toxicological drug screening?
    Maurer HH
    J Chromatogr A; 2013 May; 1292():19-24. PubMed ID: 22964051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology.
    Maurer HH
    Ther Drug Monit; 2010 Jun; 32(3):324-7. PubMed ID: 20418802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of liquid chromatography-high resolution mass spectrometry in toxicological screening].
    Li XW; Shen BH; Zhuo XY
    Fa Yi Xue Za Zhi; 2011 Oct; 27(5):376-81. PubMed ID: 22259869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of in situ derivatization techniques for enhanced bioanalysis using liquid chromatography with mass spectrometry.
    Baghdady YZ; Schug KA
    J Sep Sci; 2016 Jan; 39(1):102-14. PubMed ID: 26496130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control.
    Maurer HH
    Clin Chem Lab Med; 2004; 42(11):1310-24. PubMed ID: 15576292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of mass spectrometry in the clinical laboratory.
    Hammett-Stabler CA; Garg U
    Methods Mol Biol; 2010; 603():1-7. PubMed ID: 20077054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted screening of pesticides, veterinary drugs and mycotoxins in bakery ingredients and food commodities by liquid chromatography-high-resolution single-stage Orbitrap mass spectrometry.
    De Dominicis E; Commissati I; Suman M
    J Mass Spectrom; 2012 Sep; 47(9):1232-41. PubMed ID: 22972791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry.
    Arnhard K; Gottschall A; Pitterl F; Oberacher H
    Anal Bioanal Chem; 2015 Jan; 407(2):405-14. PubMed ID: 25366975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can analytical diagnostics in clinical toxicology be successfully performed today?
    Maurer HH
    Ther Drug Monit; 2012 Oct; 34(5):561-4. PubMed ID: 22972537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
    Marquet P
    Ther Drug Monit; 2002 Apr; 24(2):255-76. PubMed ID: 11897972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: LC coupled to low- and high-resolution mass spectrometry for new psychoactive substance screening in biological matrices - Where do we stand today?
    Meyer MR; Maurer HH
    Anal Chim Acta; 2016 Jul; 927():13-20. PubMed ID: 27237833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.